ArticleCureus2026
Interstitial Granulomatous Dermatitis Associated With Ulcerative Colitis: A Rare Cutaneous Manifestation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Interstitial granulomatous dermatitis (IGD) is a rare inflammatory dermatosis that has been associated with several autoimmune conditions, including inflammatory bowel disease. Although cutaneous manifestations are well-recognised in ulcerative colitis, IGD remains an uncommon and under-recognised extraintestinal manifestation that can mimic other inflammatory skin disorders, leading to diagnostic uncertainty. This case discusses a 36-year-old woman with a background of ulcerative colitis who presented with erythematous lesions affecting both forearms. Due to the clinical appearance of the lesions and the patient's underlying inflammatory condition, Sweet's syndrome was suspected. However, after further investigations from the dermatology department, histopathological examination demonstrated features consistent with IGD. The patient was treated with topical corticosteroids, resulting in the resolution of the lesions without recurrence. This case underscores the importance of considering IGD as a differential in patients with inflammatory bowel disease who present with atypical cutaneous lesions and emphasises the role of histopathological examination in establishing the diagnosis and guiding appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.